Article
Immunohistochemistry-quantified EGFR mutant protein expression percentage outperforms next-generation sequencing-derived mutational abundance for predicting tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Research record from Oncol Lett, 2026-11-10. PMID 43054699.
